GLORY HEALTH IND. HD-001 (84R) — Working Capital to Net Assets Ratio
GLORY HEALTH IND. HD-001 (84R) has a Working Capital to Net Assets ratio of 0.7% as of December 2025. Working capital of €78.55 Million (current assets of €28.91 Billion minus current liabilities of €28.83 Billion) is measured against net assets of €10.60 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See GLORY HEALTH IND. HD-001 (84R) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GLORY HEALTH IND. HD-001 Working Capital to Net Assets (2021–2025)
This chart shows how GLORY HEALTH IND. HD-001's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 0.7%, reflecting working capital of €78.55 Million against net assets of €10.60 Billion EUR. For the complete balance sheet picture, see total assets of GLORY HEALTH IND. HD-001.
Annual Working Capital to Net Assets for GLORY HEALTH IND. HD-001 (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GLORY HEALTH IND. HD-001 from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read 84R total debt and obligations for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 0.7% | €78.55 Million | €10.60 Billion | €28.91 Billion | €28.83 Billion | ▼ -7.8 pp |
| 2024 | 8.5% | €1.05 Billion | €12.37 Billion | €32.37 Billion | €31.31 Billion | ▲ +8.0 pp |
| 2023 | 0.5% | €67.17 Million | €13.79 Billion | €29.72 Billion | €29.65 Billion | ▲ +1.2 pp |
| 2022 | -0.7% | €-98.47 Million | €14.38 Billion | €31.22 Billion | €31.32 Billion | ▼ -36.3 pp |
| 2021 | 35.7% | €5.50 Billion | €15.43 Billion | €35.14 Billion | €29.64 Billion | — |